New Therapeutics in Alzheimer’s Disease Longitudinal Cohort study (NTAD): study protocol
- DOI
- 10.1136/bmjopen-2021-055135
- Published
- 2022-12
- Container
- BMJ Open
- Publisher
- BMJ
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1136/bmjopen-2021-055135,
title = {New Therapeutics in Alzheimer’s Disease Longitudinal Cohort study (NTAD): study protocol},
author = {Juliette Helene Lanskey and Ece Kocagoncu and Andrew J Quinn and Yun-Ju Cheng and Melek Karadag and Jemma Pitt and Stephen Lowe and Michael Perkinton and Vanessa Raymont and Krish D Singh and Mark Woolrich and Anna C Nobre and Richard N Henson and James B Rowe},
year = {2022},
journal = {BMJ Open},
doi = {10.1136/bmjopen-2021-055135},
url = {https://doi.org/10.1136/bmjopen-2021-055135}
}RIS
TY - JOUR TI - New Therapeutics in Alzheimer’s Disease Longitudinal Cohort study (NTAD): study protocol AU - Juliette Helene Lanskey AU - Ece Kocagoncu AU - Andrew J Quinn AU - Yun-Ju Cheng AU - Melek Karadag AU - Jemma Pitt AU - Stephen Lowe AU - Michael Perkinton AU - Vanessa Raymont AU - Krish D Singh AU - Mark Woolrich AU - Anna C Nobre AU - Richard N Henson AU - James B Rowe PY - 2022 JO - BMJ Open DO - 10.1136/bmjopen-2021-055135 UR - https://doi.org/10.1136/bmjopen-2021-055135 ER -
APA
Lanskey, J. H., Kocagoncu, E., Quinn, A. J., Cheng, Y., Karadag, M., Pitt, J., Lowe, S., Perkinton, M., Raymont, V., Singh, K. D., Woolrich, M., Nobre, A. C., Henson, R. N., & Rowe, J. B. (2022). New Therapeutics in Alzheimer’s Disease Longitudinal Cohort study (NTAD): study protocol. BMJ Open. https://doi.org/10.1136/bmjopen-2021-055135
Source records
- crossref · retrieved 2026-09-27T03:14:25.336Z